Transplantation of stem cells that differentiate into more mature neural cells brings about functional improvement in preclinical studies of stroke. Previous transplant approaches in the diseased brain utilized injection of the cells in a cell suspension. In addition, neural stem cells were preferentially used for grafting. However, these cells had no specific relationship to the damaged tissue of stroke and brain injury patients. The injection of cells in a suspension destroyed the cell-cell interactions that are suggested to be important for promoting functional integrity of cortical motor neurons. In order to obtain suitable cell types for grafting in patients with stroke and brain damage, a protocol was modified for differentiating human induced pluripotent stem cells from cells phenotypically related to cortical motor neurons. Moreover, cell sheet technology was applied to neural cell transplantation, as maintaining the cell-cell communications is regarded important for the repair of host brain architecture. Accordingly, neuronal cell sheets that were positive Forebrain Embryonic Zinc Finger (Fez) family zinc finger 2 (FEZF2), COUP-TF-interacting protein 2, insulin-like growth factorbinding protein 4 (IGFBP4), cysteine-rich motor neuron 1 protein precursor (CRIM1), and forkhead box p2 (FOXP2) were developed. These markers are associated with cortical motoneurons that are appropriate for the transplant location in the lesions. The sheets allowed preservation of cell-cell interactions shown by synapsin1 staining after transplantation to damaged mouse brains. The sheet transplantation brought about partial structural restoration and the improvement of motor functions in hemiplegic mice. Collectively, the novel neuronal cell sheets were transplanted into damaged motor cortices; the cell sheets maintained cell-cell interactions and improved the motor functions in the hemiplegic model mice. The motoneuron cell sheets are possibly applicable for stroke patients and patients with brain damage by using patientspecific induced pluripotent stem cells.
Introduction
Transplantation of embryonic stem cells and induced pluripotent stem cells (iPSCs) differentiated into neural precursors brings about functional improvement in preclinical studies of stroke. [1] [2] [3] [4] The transplanted cells differentiate into neurons, astrocytes, and oligodendrocytes and secrete various molecules associated with functional improvement. [5] [6] [7] In a majority of the studies, iPSC-derived neurons were transplanted into the diseased brain by injecting cell suspensions.
analyses showed improved scores in the neuron-grafted mice compared with those in vehicle-injected control mice.
To generate the cell suspension, the cells were detached from the culture dishes, resulting in the loss of cell-cell interactions and possibly influencing the functional integrity of cortical motor neurons. Human iPSC (hiPSC)-derived neural progenitor cells were transplanted into hemiplegic model mice and the motor dysfunction was ameliorated. 10 Within several months after the transplantation, the grafted cells decreased remarkably in number. Withdrawal of immunosuppressants accelerated the intracranial cell loss. 10 In addition, neural stem/progenitor cells derived from iPSCs had proliferative potential with an intrinsic risk of tumor development. 17 In order to obtain suitable cell types for grafting in patients with stroke and brain damage, a protocol was modified for differentiating hiPSCs into cells phenotypically related to cortical motor neurons. [18] [19] [20] Neuronal differentiation of hiPSCs was induced in a way mimicking cortical motor neuron development in embryos by using retinoic acid (RA), noggin (NOG), and cyclopamine (CyP). RA is an efficient inducer of neural differentiation of various cell types. 21 NOG is an essential protein that induces the neural fate of stem cells as a bone morphogenetic protein (BMP) inhibitor, 22 and CyP plays an important role in the regulation of neural stem/progenitor cell proliferation and differentiation. 23 The hiPSC-derived neurons on day 19 of in vitro culture resembled more mature cortical motor neurons of humans because they expressed forkhead box p2 (Foxp2), forebrain embryonic zinc finger family zinc finger 2 (Fezf2), and cysteine-rich motor neuron 1 protein precursor (CRIM1) simultaneously.
We hypothesized that hiPSC-derived neuronal cell sheets had enhanced neuronal differentiation and survived and functioned well after the transplantation as neural clusters consisting of differentiating cells. We expected that transplanted neuronal cell sheets formed a new cortical layer beyond the lesion including damaged cortex. In this study, we conducted histopathological and functional assessments in mice with injured brains after cell or sheet transplantation and compared the data between the 2 groups.
Materials and Methods

Induction of Neural Differentiation of hiPSCs and Neuronal Cell Sheets
The hiPSC lines, 201B7 and 253G1, 24 were purchased from RIKEN BioResource Center (Ibaraki, Japan) through the National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Because both cell lines demonstrated essentially the same results in this study, only the results obtained using 253G1 (reprogrammed by octamer-binding transcription factor 3/4 [Oct3/4], sex-determining region Y-box 2 (SOX2), and Kruppel-like factor 4 [KLF4]) were presented. The hiPSC lines were maintained according to the RIKEN cell preparation manual. Cells were cultured in differentiation medium consisting of Dulbecco's modified eagle medium (DMEM)/ F12 with N2 supplement (Thermo Fisher Scientific, Inc., Carlsbad, CA, USA).
Undifferentiated hiPSCs (253G1) were maintained in a growth medium on a feeder layer consisting of mitomycin C-treated mouse embryonic fibroblasts generated from ICR mouse embryos (Japan SLC, Shizuoka, Japan), as previously described. 25, 26 Embryoid bodies were developed in a floating condition for 4 d (from day 0 to day 4). Then the cells were cultured in fibronectin-coated dishes (Corning Inc., Corning, NY, USA) for 4 d (from day 4 to day 8). RA of 1 mM (Sigma-Aldrich, Tokyo, Japan), 10 nM NOG (R&D Systems, Minneapolis, MN, USA), and 2.5 pM CyP (Enzo Life Sciences, Farmingdale, NY, USA) were introduced into the dishes twice on days 5 and 7. The cells were harvested on day 8, and the cell suspensions were transplanted into mice as transplantation controls (neural stem/progenitor cells).
An aliquot of the cells was cultured in 24-well culture plates for 12-16 d, which were then harvested using trypsin/ ethylenediaminetetraacetic acid (EDTA) (Thermo Fisher Scientific, Inc.) solution for transplantation. The remaining cells were cultured on temperature-responsive gelation polymer-coated plate (temp. resp. polymer; Upcell1, CellSeed, Tokyo, Japan) for 12-16 d (average 14 d) depending on the neuronal maturation, where they extended axon-like processes, leading to the formation of neuronal cell sheets. To initiate cell sheet formation, 1.0 Â 10 6 cells/well were introduced in the 24-well plates, and the resulting cell sheets contained 0.4-1.0 Â 10 6 cells/sheet. The plates were transferred to another incubator, set at 22 C, for 1 h to release the cultured cells as intact cell sheets. Under this protocol, confluent neuronal cell sheets were spontaneously detached from the plates (Fig. 1B-G) .
Real-time Polymerase Chain Reaction (RT-PCR)
Total RNA was isolated from cells with an RNeasy kit (Qiagen, Hilden, Germany). Complementary DNA was synthesized with TaqMan reverse transcription reagents (Applied Biosystems, Foster City, CA, USA) in accordance with the manufacturer's instructions. Briefly, relative messenger RNA (mRNA) levels were measured by quantitative RT-PCR. TaqMan probes specific for the targeted gene as well as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an endogenous control (Life Technologies, see for TaqMan probe IDs) were used.
Experimental Brain Injury and Transplantation
To use genetically normal mice, female C57BL/6 mice (6 to 8 weeks old; Japan SLC) were used as transplant recipients. 28, 29 All experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals, 8th edition (National Research Council) and were approved by the local Animal Care Committee (Animal Care and Use Committee, St. Marianna University School of Medicine).
Procedures for induction of brain injury and for subsequent transplantation of neural cells are described previously. 10, 25, 26, 28, 29 Briefly, for induction of brain injury, a burr hole mark was made in the right parietal bone at the location of 0.5 mm anterior and 2.0 mm lateral to the bregma. A metal probe chilled with liquid nitrogen was applied to the surface of the intact burr hole marks by force of 100 g for 30 s, 4 times.
Eight days after the injury, the neuronal cells or neuronal cell sheets were transplanted into the brain-injured mice. One of the following were transplanted to the hemiplegic mice: single-cell suspension of motor neurons that were cultured for 24 d (1.0 Â 10 5 cells, n ¼ 9) or the cell sheets (0.4-1.0 Â 10 6 cells/sheet, n ¼ 11; Fig. 2 ). For the neuronal cell sheet transplantation, the sheets were placed on the brain surface through the burr hole. The sheets were covered with thermo-reversible gelation polymers which had the reversible solgel process by temperature 30, 31 to retain the binding activity of the sheets in the injured brain. Immunosuppressants were administered as reported previously 10, 25 ; 10 mg/kg cyclosporine (Novartis Pharmaceuticals Tokyo, Japan) and 0.2 mg/kg dexamethasone (Sigma-Aldrich, St. Louis, MO, USA) were administered to all mouse groups 1 h before the transplantation. Ten milligram/kilogram cyclosporine was given once a day from the next day of the transplantation until the mouse was sacrificed.
As transplantation controls, single-cell suspensions of neural cells at day 8, which were strongly positive for nestin (1.0 Â 10 5 cells, n ¼ 6) and vehicle (phosphatebuffered saline (PBS), n ¼ 11), were injected through the burr hole and 2.0 mm ventral to the dura with a 5-ml Hamilton syringe (Hamilton Company, Reno, NV, USA) attached to a 26-gauge needle.
All surgical interventions, pre-and postsurgical animal care, and euthanasia followed the Guide for the Care and Use of Laboratory Animals, 8th edition (National Research Council) and were approved by the local Animal Care . In some experiments, sonic hedgehog (SHH) were introduced instead of adding CyP, together with RA and NOG in order to compare the effects of CyP with those of SHH. Thereafter, the cells cultured with RA, NOG, and CyP were harvested on day 8. An aliquot of the cells was cultured in 24-well culture plates for 12 to 16 d and then harvested using trypsin/ethylenediaminetetraacetic acid (EDTA) solution for transplantation. The remaining cells were cultured on temperatureresponsive gelation polymer-coated plate (temp. resp. polymer) for 12 to 16 d depending on the neuronal maturation, where they extended axon-like processes, leading to the formation of neuronal cell sheet. The neuronal cell sheet was recovered by lowering the temperature of culture plate below 22 C. Schedule for brain injury, transplantation, and motor function test was reported previously. 10, 20, 28, 29 The cells on day 8 were used as neural stem/ progenitor cells for comparison. . neuronal cell sheet. For comparison, neural cells on day 8 (neural cells were cultured in the same manner except that SHH was added instead of CyP and were harvested on day 8 before making cell sheet) were included. The cell sheet expressed Foxp2, Fezf2, Igfbp4, CTIP2, and synaptophysin mRNA predominantly. CRIM1 mRNA was expressed throughout the culture period. Thus, the cell sheet expressed mRNAs of cortical motoneuron-associated proteins. A white horizontal bar represents 200 mm in panel D, 100 mm in panels E and F, and 50 mm in panel G. UiPSCs, undifferentiated-induced pluripotent stem cells; CRIM1, cysteine-rich motor neuron 1 protein precursor; MEF, mouse embryonic fibroblasts; floating indicates floating condition; Foxp2, forkhead box p2; Fezf2, forebrain embryonic zinc finger family zinc finger 2; Igfbp4, insulin-like growth factor-binding protein 4; CTIP2, COUP-TF-interacting protein 2; mRNA, messenger RNA.
Committee (Institutional Animal Care and Use Committee (IACUC)).
Motor Function Analyses: Beam Walking Test and Rotarod Test
The beam walking test allows the assessment of refined forelimb and hind limb locomotor activity and is used to assess the recovery of the hemiplegic model of brain injury. 1, 6, 32, 33 The animals were trained to walk along a narrow wooden beam of 6 mm wide and 120 mm length, which was suspended at 300 mm above a soft pad, and the number of foot faults for the contralateral (right) hind limb was recorded over 50 steps. Foot faults were directly observed in accordance with gait disturbance and were counted. Normal mice grasped the beam completely on every foot, and the foot fault was defined as that without complete grasp of the beam. A basal level of competence at this test was established before injury with an acceptance level of <5 faults per 50 steps.
The rotarod test allows the assessment of refined motor function and coordination and is used to assess the recovery of hemiplegic model of brain injury. 6, 32, 33 For each mouse, the rotarod unit (Muromachi, Tokyo, Japan) consists of a rotating rod of 3.5 cm diameter and an individual compartment. Infrared beams were used to check whether the mouse had fallen onto the grid beneath the rotarod. Before brain injury, mice was trained on the rotarod and a basal level of competence was established at this test, with an acceptance level of >200 s at a speed of 20 rpm. After injury, the mice were placed on the rod and then run on the rotarod at 30 rpm for the maximum of 300 s. The system logged the total time running on the rod as well as the time of the fall, and all experimental set up parameters were recorded. The mice were given 5-min intervals in order to reduce stress and fatigue. Each animal received at least 2 consecutive trials, with the longer time on the rod used for analysis.
Immunofluorescence Staining
Immunofluorescence staining was conducted as reported previously. 10, 25, 26, 28, 29 The following antibodies were used: rabbit anti-neurofilament middle chain (Millipore, Billerica, MA, USA), mouse anti-bIII tubulin (Promega, Madison, WI, USA), rabbit anti-CRIM1 (Sigma-Aldrich), rat anti-CTIP2 (Abcam, Cambridge, MA, USA), anti-Fezf2 (Abcam), rabbit anti-Foxp2 (Abcam), mouse anti-human Neural cell adhesion molecule (NCAM) (hNCAM; Santa Cruz Biotechnology, Dallas, TX, USA), antisynapsin1 (Millipore), rabbit anti-Nanog (ReproCELL, Kanagawa, Japan), mouse antiOct3/4 (Santa Cruz Biotechnology), rabbit anti-Pax6 (BioLegend, San Diego, CA, USA), and mouse anti-human nuclei (Abnova, Taipei City, Taiwan).
Statistical Analysis
All statistical analyses were performed using JMP 8.0.2 software (SAS Institute Japan, Tokyo, Japan). Each point in Fig. 3 represented mean + standard error of the mean (SEM) of the mouse groups. Continuous variables subjected to repeated measurements over a period of time on the beam walking and rotarod test were analyzed using a multivariate analysis of variance (MANOVA), followed by Tukey's honestly significant difference. P value less than 0.05 was considered significant.
Results
Induction of Neural Differentiation of hiPSCs and Formation of Neuronal Cell Sheets
Cell sheets composed of motor neurons were made in a laminar array, resembling anatomy of the cortical motor area (Fig. 1) . Using a combination of RA, NOG, and CyP, substantially pure mature neurons were obtained from hiPSCs. RT-PCR analyses revealed that they were COUP-TFinteracting protein 2 (CTIP2) positive and Fezf2 positive (Fig. 1H) , both of which were cortical motor neuronspecific transcription factors.
15,34-38 They expressed insulin-like growth factor-binding protein 4 (IGFBP4) mRNA (Fig. 1H) . 39 The neurons in the cell sheet (day 21) expressed 600 times more synaptophysin mRNA than those before making cell sheet (cells at day 8) using quantitative RT-PCR with 2
ÀDDCt method of TaqMan primers and probe (data not shown).
By immunofluorescence, these cells were almost completely positive for human nuclear antigen and bIII tubulin (b-tubulin; Fig. 1F and G) .
To further characterize cells in the sheets, the sheets were stained with several antibodies (Fig. 2) . Cells in the sheets lacked protein expressions of Nanog, Oct3/4, and Pax6, suggesting their differentiation. Undifferentiated hiPSCs expressed these antigens. Cells in the sheets were negative for alkaline phosphatase which had been positive on the undifferentiated hiPSCs (data not shown). They expressed motor neuron associated and positional antigens extensively, corresponding to the cortical motor area, 27 ,38 such as Fezf2, CTIP2 Foxp2, and CRIM1. They were approximately 76% Fezf2 positive, 29% CTIP2 positive, 41% Foxp2 positive, and 72% CRIM1 positive.
After transplanting neuronal cell sheet with polymer coverage, the sheets were observed to be well attached to the brain surface of injured mice (Fig. 3) .
Grafted Cell Sheet Significantly Improved Motor Function in Injured Hemiplegic Mice
The cells were cultured on a temperature-dependent gelation polymer-coated plate (Upcell CellSeed). The cell sheet was recovered by lowering the temperature to provoke sheet detachment without using trypsin. The cell sheet was grafted to hemiplegic mice developed as previously reported. 20, 26 In the beam walking test, motor performance was measured as the number of foot faults in 50 steps. Although the scores were zero in normal control mice, the scores in the mice that had right hemiplegia caused by the injury at days 2 and 5 were almost 50, namely, 100% as in Fig. 4A . Thereafter, the scores were gradually improved in the cell sheettransplanted mice. Even using the same neuronal cells cultured for 24 d, mice with sheet transplantation improved more efficiently than mice with injection of single-cell suspension. The scores between the mice injected with singlecell suspension of the neuronal cells cultured for 24 d and those transplanted with the neural cell sheet (cultured for 24 d) were statistically significant (MANOVA, P < 0.01; Fig.  4A ). However, the scores of the sheet-transplanted mice remained higher than those of intact control mice, during the observation period (Fig. 4A) .
To confirm recovery of motor function in the transplanted mice, a rotarod test was conducted to measure the duration a mouse can stay on the rotating rod, reflecting refined motor function and coordination. 29, 32 Most efficient recovery of the duration time in the rotarod test was observed in the mice transplanted with the neuronal cell sheet as compared with those treated with single-cell suspensions of 24-d cultured neurons and with PBS injection (Fig. 4B) . It appeared that preservation of cell-to-cell interaction was effectively associated with the functional recovery of the hemiplegic mice.
Difference in the duration time of rotarod test and that of the score of beam walking test between cell sheet recipient mice and mice injected with single-cell suspension of neural stem/progenitor cells (neural cells at day 8) did not show the statistical significance.
Collectively, transplantation with the neuronal cell sheet restored motor function efficiently in the hemiplegia mouse to an extent similar to that with neural stem/progenitor cells.
Neurons Derived from hiPSCs Migrated into the Damaged Cortex from the Cell Sheet and Formed a Cell Layer of Motoneuron Phenotype
hNCAMþ and human nuclearþ cells resided in the cell sheet 21 d after transplantation (Fig. 5A, B, D) . Some of them entered the damaged cortex and showed synapsin1 expression, suggesting possible neural connections between human and mouse neurons (Fig. 5A and B) . Most of them were CTIP2, Fezf2, and Foxp2 positive located at both the grafted sheet and damaged cortex (Fig. 5B-E) .
It was noteworthy that the neurons with motoneuron phenotype formed a cell layer underneath the cells of nonmotoneuron phenotype (Fig. 5A, B, C, D, and F) , in contrast to the wide distribution of grafts across the cortex in cell-transplanted mice (Fig. 5G) .
Discussion
We successfully generated cortical motor neurons in the cell sheet derived from hiPSCs. The cell sheet was suggested to be functional in the mouse intracranial space and to provide neurons to the damaged cortex (Fig. 5) . Some cells entered the damaged cortex and showed expression of synapsin1 and Mice injected with single-cell suspension of neural (stem/progenitor) cells at day 8 exhibited functional recovery almost to an extent similar to mice with the cell sheet transplant. "I" and "T" indicate injury and transplantation, respectively. *, **, y, and yy indicate P < 0.0001, P < 0.001, P < 0.01, and P < 0.02, respectively. human CRIM1 (Fig. 5A and data not shown) . It was thus suggested that the human neurons having a cortical motor neuron phenotype survived and connected with the host neural circuit to bring about motor functional improvement. 27 We have clearly shown that functional recovery of mice treated with the cell sheet transplantation method far exceeded that of mice treated by injection of dissociated neurons of similar in vitro maturity.
Neural stem/progenitor cells possess a wider range of therapeutic properties for neural repair than mature neurons. Because of their proliferative capability, hiPSC-derived neural stem/progenitor cell transplantation had a tumor development feature. 17 They show functional neuronal replacement, delivery of neurotrophic factors synthesized by themselves, mitigation of toxic and/or inflammatory components of the neural environment, and replacement of multiple neural elements that define a given central nervous system (CNS) region. [40] [41] [42] [43] [44] [45] Indeed, our preliminary experiments revealed that cells in the sheet cultured for 24 d scarcely expressed mRNAs of human nerve growth factor (hNGF), human brain-derived neurotrophic factor (hBDNF), and human neurotrophin-3 (hNT3). In contrast, our neural stem/progenitor cells at day 8 expressed mRNAs of hNGF, hBDNF, and hNT3 sufficiently (manuscript in preparation). Human glial cell line-derived neurotrophic factor (hGDNF) mRNA expression was marginal in both sheet cells (cultured for 24 d) and neural stem/ progenitor cells (cultured for 8 d). Thus, it is possible that the growth factors produced by our neural stem/progenitor cells at day 8 contributed partly to the functional recovery of the mice injected with cells. Neuronal cell sheet transplantation supplemented exogenously with the growth factors may lead to more efficient functional recovery of the hemiplegic mice. Further study is needed to bring about more efficient recovery of mouse motor functions.
We and others found that human neural stem/progenitor cells integrated into host neural circuitry after transplantation into damaged CNS of adult rodent. [40] [41] [42] Nonetheless, neuronal cell sheet transplantation exhibited efficient functional recovery to an extent similar to neural stem/progenitor cell transplantation (Fig. 4) .
Recently, several researchers revealed that ipsilateral transplantation of neuronal cell sheets derived from bone marrow stromal cells restored the motor function of a stroke model. 46 The sheet transplantation was accompanied by less reactive accumulation of astrocytes compared to direct cell injection. We suggest that cell sheet transplantation is a promising therapeutic strategy for patients with hemiplegia.
Thus, cell sheets were less likely to form tumors and existed as a purer population of neurons, without the usual contaminating cell types in progenitor cell sources. Indeed, we did not observe any tumor formation in the brains of the sheet recipients.
We found that Fezf2-positive human neurons made a cell layer underneath the Fezf2-negative human neurons, resembling a layered structure of motoneurons (Fig. 5D) . A similar layered structure was observed when CTIP2 and Foxp2 antibodies were employed ( Fig. 5B and E) . We hardly detected a layered structure of motoneurons when a singlecell suspension of motoneurons was injected into the brain. 10, 20, 26, 28 The histological restoration of the current sheet transplantation is far different from the layered structure of an intact motor cortex. Nonetheless, further modification of the sheet may bring about fine structural reorganization and efficient functional improvement in the damaged motor cortex.
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